Post Views: 107 Non-small cell lung cancer continues to remain one of the main reasons behind cancer related deaths all across the world. Continuous studies and research works are going on that…
Search Results for: chemotherapy
Combination Of Radiation And Immunotherapy For Advanced Non-Small Cell Lung Cancer
Post Views: 95 According to the new study by researchers from the UCLA Health Jonsson Comprehensive Cancer Center, using high doses of radiation with an ablative radiotherapy technique is effective for treatment…
FDA Places Hold on Iovance’s Lung Cancer Treatment Trial
Post Views: 195 Lung cancer is one of the most deadly diseases all around the world. Various companies are during clinical trials to offer better and effective treatment options for those suffering…
Dizal Published New Pivotal Phase II Trial Data on Sunvozertinib in NSCLC
Post Views: 305 Shanghai-based biopharmaceutical company, Dizal, has published new Pivotal Phase II Trial Data on sunvozertinib in non-small cell lung cancer (NSCLC). Sunvozertinib is an oral and selective tyrosine kinase inhibitor…
Durvalumab for Treatment of Lung Cancer
Post Views: 279 Durvalumab is a type of immunotherapy and is known by its brand name, Imfinzi. Its role in treatment of small cell lung cancer is increasing. Durvalumab injection is injected…
Trial Shows Novel Vaccine’s Potential for Lung Cancer Treatment
Post Views: 169 A new vaccine has shown to improve survival rate among people suffering from lung cancer. A French biotechnology company said that Ose Immunotherapeutics’ Tedopi vaccine was effective in decreasing death…
Quratusugene Ozeplasmid for Small Cell Lung Cancer Receives Orphan Drug Designation by FDA
Post Views: 212 Genprex, Inc. is a clinical-stage gene therapy company and has announced the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to the drug, Reqorsa…
Lung Cancer Drug, Osimertinib, Drastically Reduces Death Risk after Surgery
Post Views: 171 Lung cancer is among most common types of cancers in U.S. as well as around the world. According to the Centers for Disease Control and Prevention, it is responsible…
Older Age Lung Cancer Patients
Post Views: 110 This is a fact accepted worldwide with evidences that lung cancer is old age disease. Lung cancer patients more then 50% are diagnosed after the age of 65, while…
Lung Cancer Outcomes May Be Improved By Chemo With TKI Drug
Post Views: 128 Gefitinib and chemotherapy may be considered a first-line treatment option for patients with EGFR-mutated Non-Small Cell Lung Cancer (NSCLC) with brain metastases. Recent research has shown that patients with…
FDA Approves Adjuvant Pembrolizumab for Non-Small Cell Lung Cancer Treatment
Post Views: 128 The US Food and Drug Administration has approved Pembrolizumab for adjuvant treatment following resection and platinum-based chemotherapy in patients with NSCLC (non-small cell lung cancer). This approval has been…
U.S. FDA Approves Lung Cancer Drug, Adagrasib
Post Views: 126 The US Food and Drug Administration (FDA) has granted accelerated approval for Mirati Therapeutics’ Krazati (adagrasib) for treatment of mutated locally advanced or metastatic non-small cell lung cancer in…